Artificial intelligence is accelerating drug development and lowering costs across the pharmaceutical industry, potentially boosting operating profits by more than 10%, according to Bernstein.

The Generic Drugs Market has emerged as one of the most critical segments of the global pharmaceutical industry due to its ability to provide affordable and effective alternatives to branded ...

Over the next 5 years, Gland Pharma plans to invest approximately Rs 20 bn in capex, primarily towards BFS and ophthalmic ...

From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...

The updated guidance allows originators to cite existing comparative data, not exclusively from the United States, for clinical pharmacokinetic testing.

WINNIPEG, MB - March 05, 2026 - PRESSADVANTAGE - BuyCanadianInsulin.com reports that generic semaglutide may become ...

This framework is the second that the agency has introduced in recent months to streamline biosimilar development in the hopes of lowering drug prices.

Months after promising help for “hundreds of thousands of kids,” the FDA approved the decades-old medicine for a disease ...

After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.

Pharmaceutical companies in India are driving innovation, biosimilars, APIs & global exports while strengthening research, manufacturing & healthcare access.

In another development, 25 states have petitioned to join a lawsuit and defend the EPA’s decision to rescind the climate endangerment finding ...

The biotech industry has delivered an upbeat performance so far in 2026 despite an uncertain macroeconomic backdrop. Strong ...